Loading…
A review on ameliorative green nanotechnological approaches in diabetes management
Managerial pathways showing anti-diabetic action of different metallic nanoparticles (A) flavonoids and glycosides coated MNPs (B) Terpenoids and flavonoids coated MNPs (C) MNPs inhibits the α-amylase and α-glucosidase. [Display omitted] •Diabetes mellitus is a chronic metabolic disorder due to hype...
Saved in:
Published in: | Biomedicine & pharmacotherapy 2020-07, Vol.127, p.110198-110198, Article 110198 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c408t-2e317dcda0d0ec00a7539cd5eeba7983170b76742225128ca9f0ec0659cc75ab3 |
---|---|
cites | cdi_FETCH-LOGICAL-c408t-2e317dcda0d0ec00a7539cd5eeba7983170b76742225128ca9f0ec0659cc75ab3 |
container_end_page | 110198 |
container_issue | |
container_start_page | 110198 |
container_title | Biomedicine & pharmacotherapy |
container_volume | 127 |
creator | Bhardwaj, Monika Yadav, Poonam Dalal, Sunita Kataria, Sudhir Kumar |
description | Managerial pathways showing anti-diabetic action of different metallic nanoparticles (A) flavonoids and glycosides coated MNPs (B) Terpenoids and flavonoids coated MNPs (C) MNPs inhibits the α-amylase and α-glucosidase.
[Display omitted]
•Diabetes mellitus is a chronic metabolic disorder due to hyperglycaemic condition mainly due to insufficient insulin secretion or body fails to respond to secreted insulin from pancreatic cells and is the third cause of death worldwide after cardiovascular diseases and cancer.•Nanotechnology is an emerging area in pharmaceutical sciences as nanoparticles mainly silver, zinc oxide, gold, chitosan etc synthesized using different plant resources as various secondary metabolites like saponins, flavonoids, steroids, alkaloids, and tannins, increases the efficacy of drugs by their target specific activity and play pivotal role in management of disease.•The green metallic nanotechnological approaches revealed antibiabetic potential and assisted in understanding various therapeutic processes and manipulated significantly regulatory mechanism/s pertaining to management of diabetes through pancreatic α-amylase, intestinal α-glucosidase, insulin secretion or its action, glucose uptake, receptor affinity and other biochemical/histological parameters in different in vivo and in vitro systems.•The furtherance of nanotechnological approaches about exploration of herbal chemical potential may lead to consideration of certain novel magic drug molecules for better management of diabetes and other diseases.•The nanotechnology is expanding its wings to cater its beneficial effects in fields like drug delivery system, cosmetics, agriculture, tissue engineering, diagnostic systems, and management of various diseases.
Diabetes mellitus is a chronic metabolic disorder which results in increase of blood glucose level mainly due to insufficient insulin secretion or body fails to respond to secreted insulin from pancreatic cells. Diabetes is mainly the third cause of death worldwide after cardiovascular diseases and cancer. Nanotechnology is an emerging area in pharmaceutical sciences as nanoparticles are reported to increase the efficacy of drugs derived from plant resources by their target specific activity. The nanomaterials synthesized from plant resources have regulatory potential in control of certain diseases with minimum or no side effects. The review focuses on the reported antidiabetic potential of different metallic and other nanoparticl |
doi_str_mv | 10.1016/j.biopha.2020.110198 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2415302340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332220303905</els_id><sourcerecordid>2415302340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-2e317dcda0d0ec00a7539cd5eeba7983170b76742225128ca9f0ec0659cc75ab3</originalsourceid><addsrcrecordid>eNp9kEtPwzAMgCMEYmPwDxDqkUuHmzR9XJAQ4iVNQkJwjtzU2zK1yUg6EP-eTAWOnGLZn2P7Y-w8g3kGWXG1mTfGbdc458BjKubq6oBNs1pCWgCUh2wKpRSpEJxP2EkIGwCQhaiO2URwKesql1P2cpN4-jD0mTibYE-dcR4H80HJyhPZxKJ1A-m1dZ1bGY1dgtutd6jXFBJjk9ZgQ0OMe7S4op7scMqOltgFOvt5Z-zt_u719jFdPD883d4sUp1DNaScRFa2ukVogTQAxmVr3UqiBsu6ikVoyqLMOecy45XGernnCllrXUpsxIxdjv_Gfd53FAbVm6Cp69CS2wXF80wK4CKHiOYjqr0LwdNSbb3p0X-pDNTeptqo0aba21Sjzdh28TNh1_TU_jX96ovA9QhQvDNa9CpoQ1ZTazzpQbXO_D_hGxueiCE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2415302340</pqid></control><display><type>article</type><title>A review on ameliorative green nanotechnological approaches in diabetes management</title><source>Elsevier</source><creator>Bhardwaj, Monika ; Yadav, Poonam ; Dalal, Sunita ; Kataria, Sudhir Kumar</creator><creatorcontrib>Bhardwaj, Monika ; Yadav, Poonam ; Dalal, Sunita ; Kataria, Sudhir Kumar</creatorcontrib><description>Managerial pathways showing anti-diabetic action of different metallic nanoparticles (A) flavonoids and glycosides coated MNPs (B) Terpenoids and flavonoids coated MNPs (C) MNPs inhibits the α-amylase and α-glucosidase.
[Display omitted]
•Diabetes mellitus is a chronic metabolic disorder due to hyperglycaemic condition mainly due to insufficient insulin secretion or body fails to respond to secreted insulin from pancreatic cells and is the third cause of death worldwide after cardiovascular diseases and cancer.•Nanotechnology is an emerging area in pharmaceutical sciences as nanoparticles mainly silver, zinc oxide, gold, chitosan etc synthesized using different plant resources as various secondary metabolites like saponins, flavonoids, steroids, alkaloids, and tannins, increases the efficacy of drugs by their target specific activity and play pivotal role in management of disease.•The green metallic nanotechnological approaches revealed antibiabetic potential and assisted in understanding various therapeutic processes and manipulated significantly regulatory mechanism/s pertaining to management of diabetes through pancreatic α-amylase, intestinal α-glucosidase, insulin secretion or its action, glucose uptake, receptor affinity and other biochemical/histological parameters in different in vivo and in vitro systems.•The furtherance of nanotechnological approaches about exploration of herbal chemical potential may lead to consideration of certain novel magic drug molecules for better management of diabetes and other diseases.•The nanotechnology is expanding its wings to cater its beneficial effects in fields like drug delivery system, cosmetics, agriculture, tissue engineering, diagnostic systems, and management of various diseases.
Diabetes mellitus is a chronic metabolic disorder which results in increase of blood glucose level mainly due to insufficient insulin secretion or body fails to respond to secreted insulin from pancreatic cells. Diabetes is mainly the third cause of death worldwide after cardiovascular diseases and cancer. Nanotechnology is an emerging area in pharmaceutical sciences as nanoparticles are reported to increase the efficacy of drugs derived from plant resources by their target specific activity. The nanomaterials synthesized from plant resources have regulatory potential in control of certain diseases with minimum or no side effects. The review focuses on the reported antidiabetic potential of different metallic and other nanoparticles mainly silver, zinc oxide, gold, copper, selenium, chitosan and iron oxide, synthesized using different plant resources as various secondary metabolites like saponins, flavonoids, steroids, alkaloids, tannins. The green nanotechnological approach reported their antibiabetic potential as magic molecules in understanding various therapeutic processes and manipulated significantly regulatory mechanism/s pertaining to management of diabetes through pancreatic α-amylase, intestinal α-glucosidase, insulin action, glucose uptake in different in vivo and in vitro systems. The additional inputs of nanotechnological approaches regarding further exploration of herbal chemical potential may lead to consideration of certain novel magic drug molecules and may act as an advantage in management of diabetes for betterment of mankind.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2020.110198</identifier><identifier>PMID: 32559845</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Diabetes ; Diabetes Mellitus - drug therapy ; Disease Management ; Drug Compounding - methods ; glucose uptake assays ; Humans ; insulin ; nanoparticles ; Nanotechnology - methods ; secondary metabolites ; α-amylase</subject><ispartof>Biomedicine & pharmacotherapy, 2020-07, Vol.127, p.110198-110198, Article 110198</ispartof><rights>2020 The Authors</rights><rights>Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-2e317dcda0d0ec00a7539cd5eeba7983170b76742225128ca9f0ec0659cc75ab3</citedby><cites>FETCH-LOGICAL-c408t-2e317dcda0d0ec00a7539cd5eeba7983170b76742225128ca9f0ec0659cc75ab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32559845$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhardwaj, Monika</creatorcontrib><creatorcontrib>Yadav, Poonam</creatorcontrib><creatorcontrib>Dalal, Sunita</creatorcontrib><creatorcontrib>Kataria, Sudhir Kumar</creatorcontrib><title>A review on ameliorative green nanotechnological approaches in diabetes management</title><title>Biomedicine & pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>Managerial pathways showing anti-diabetic action of different metallic nanoparticles (A) flavonoids and glycosides coated MNPs (B) Terpenoids and flavonoids coated MNPs (C) MNPs inhibits the α-amylase and α-glucosidase.
[Display omitted]
•Diabetes mellitus is a chronic metabolic disorder due to hyperglycaemic condition mainly due to insufficient insulin secretion or body fails to respond to secreted insulin from pancreatic cells and is the third cause of death worldwide after cardiovascular diseases and cancer.•Nanotechnology is an emerging area in pharmaceutical sciences as nanoparticles mainly silver, zinc oxide, gold, chitosan etc synthesized using different plant resources as various secondary metabolites like saponins, flavonoids, steroids, alkaloids, and tannins, increases the efficacy of drugs by their target specific activity and play pivotal role in management of disease.•The green metallic nanotechnological approaches revealed antibiabetic potential and assisted in understanding various therapeutic processes and manipulated significantly regulatory mechanism/s pertaining to management of diabetes through pancreatic α-amylase, intestinal α-glucosidase, insulin secretion or its action, glucose uptake, receptor affinity and other biochemical/histological parameters in different in vivo and in vitro systems.•The furtherance of nanotechnological approaches about exploration of herbal chemical potential may lead to consideration of certain novel magic drug molecules for better management of diabetes and other diseases.•The nanotechnology is expanding its wings to cater its beneficial effects in fields like drug delivery system, cosmetics, agriculture, tissue engineering, diagnostic systems, and management of various diseases.
Diabetes mellitus is a chronic metabolic disorder which results in increase of blood glucose level mainly due to insufficient insulin secretion or body fails to respond to secreted insulin from pancreatic cells. Diabetes is mainly the third cause of death worldwide after cardiovascular diseases and cancer. Nanotechnology is an emerging area in pharmaceutical sciences as nanoparticles are reported to increase the efficacy of drugs derived from plant resources by their target specific activity. The nanomaterials synthesized from plant resources have regulatory potential in control of certain diseases with minimum or no side effects. The review focuses on the reported antidiabetic potential of different metallic and other nanoparticles mainly silver, zinc oxide, gold, copper, selenium, chitosan and iron oxide, synthesized using different plant resources as various secondary metabolites like saponins, flavonoids, steroids, alkaloids, tannins. The green nanotechnological approach reported their antibiabetic potential as magic molecules in understanding various therapeutic processes and manipulated significantly regulatory mechanism/s pertaining to management of diabetes through pancreatic α-amylase, intestinal α-glucosidase, insulin action, glucose uptake in different in vivo and in vitro systems. The additional inputs of nanotechnological approaches regarding further exploration of herbal chemical potential may lead to consideration of certain novel magic drug molecules and may act as an advantage in management of diabetes for betterment of mankind.</description><subject>Diabetes</subject><subject>Diabetes Mellitus - drug therapy</subject><subject>Disease Management</subject><subject>Drug Compounding - methods</subject><subject>glucose uptake assays</subject><subject>Humans</subject><subject>insulin</subject><subject>nanoparticles</subject><subject>Nanotechnology - methods</subject><subject>secondary metabolites</subject><subject>α-amylase</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAMgCMEYmPwDxDqkUuHmzR9XJAQ4iVNQkJwjtzU2zK1yUg6EP-eTAWOnGLZn2P7Y-w8g3kGWXG1mTfGbdc458BjKubq6oBNs1pCWgCUh2wKpRSpEJxP2EkIGwCQhaiO2URwKesql1P2cpN4-jD0mTibYE-dcR4H80HJyhPZxKJ1A-m1dZ1bGY1dgtutd6jXFBJjk9ZgQ0OMe7S4op7scMqOltgFOvt5Z-zt_u719jFdPD883d4sUp1DNaScRFa2ukVogTQAxmVr3UqiBsu6ikVoyqLMOecy45XGernnCllrXUpsxIxdjv_Gfd53FAbVm6Cp69CS2wXF80wK4CKHiOYjqr0LwdNSbb3p0X-pDNTeptqo0aba21Sjzdh28TNh1_TU_jX96ovA9QhQvDNa9CpoQ1ZTazzpQbXO_D_hGxueiCE</recordid><startdate>202007</startdate><enddate>202007</enddate><creator>Bhardwaj, Monika</creator><creator>Yadav, Poonam</creator><creator>Dalal, Sunita</creator><creator>Kataria, Sudhir Kumar</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202007</creationdate><title>A review on ameliorative green nanotechnological approaches in diabetes management</title><author>Bhardwaj, Monika ; Yadav, Poonam ; Dalal, Sunita ; Kataria, Sudhir Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-2e317dcda0d0ec00a7539cd5eeba7983170b76742225128ca9f0ec0659cc75ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Diabetes</topic><topic>Diabetes Mellitus - drug therapy</topic><topic>Disease Management</topic><topic>Drug Compounding - methods</topic><topic>glucose uptake assays</topic><topic>Humans</topic><topic>insulin</topic><topic>nanoparticles</topic><topic>Nanotechnology - methods</topic><topic>secondary metabolites</topic><topic>α-amylase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhardwaj, Monika</creatorcontrib><creatorcontrib>Yadav, Poonam</creatorcontrib><creatorcontrib>Dalal, Sunita</creatorcontrib><creatorcontrib>Kataria, Sudhir Kumar</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine & pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhardwaj, Monika</au><au>Yadav, Poonam</au><au>Dalal, Sunita</au><au>Kataria, Sudhir Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A review on ameliorative green nanotechnological approaches in diabetes management</atitle><jtitle>Biomedicine & pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2020-07</date><risdate>2020</risdate><volume>127</volume><spage>110198</spage><epage>110198</epage><pages>110198-110198</pages><artnum>110198</artnum><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>Managerial pathways showing anti-diabetic action of different metallic nanoparticles (A) flavonoids and glycosides coated MNPs (B) Terpenoids and flavonoids coated MNPs (C) MNPs inhibits the α-amylase and α-glucosidase.
[Display omitted]
•Diabetes mellitus is a chronic metabolic disorder due to hyperglycaemic condition mainly due to insufficient insulin secretion or body fails to respond to secreted insulin from pancreatic cells and is the third cause of death worldwide after cardiovascular diseases and cancer.•Nanotechnology is an emerging area in pharmaceutical sciences as nanoparticles mainly silver, zinc oxide, gold, chitosan etc synthesized using different plant resources as various secondary metabolites like saponins, flavonoids, steroids, alkaloids, and tannins, increases the efficacy of drugs by their target specific activity and play pivotal role in management of disease.•The green metallic nanotechnological approaches revealed antibiabetic potential and assisted in understanding various therapeutic processes and manipulated significantly regulatory mechanism/s pertaining to management of diabetes through pancreatic α-amylase, intestinal α-glucosidase, insulin secretion or its action, glucose uptake, receptor affinity and other biochemical/histological parameters in different in vivo and in vitro systems.•The furtherance of nanotechnological approaches about exploration of herbal chemical potential may lead to consideration of certain novel magic drug molecules for better management of diabetes and other diseases.•The nanotechnology is expanding its wings to cater its beneficial effects in fields like drug delivery system, cosmetics, agriculture, tissue engineering, diagnostic systems, and management of various diseases.
Diabetes mellitus is a chronic metabolic disorder which results in increase of blood glucose level mainly due to insufficient insulin secretion or body fails to respond to secreted insulin from pancreatic cells. Diabetes is mainly the third cause of death worldwide after cardiovascular diseases and cancer. Nanotechnology is an emerging area in pharmaceutical sciences as nanoparticles are reported to increase the efficacy of drugs derived from plant resources by their target specific activity. The nanomaterials synthesized from plant resources have regulatory potential in control of certain diseases with minimum or no side effects. The review focuses on the reported antidiabetic potential of different metallic and other nanoparticles mainly silver, zinc oxide, gold, copper, selenium, chitosan and iron oxide, synthesized using different plant resources as various secondary metabolites like saponins, flavonoids, steroids, alkaloids, tannins. The green nanotechnological approach reported their antibiabetic potential as magic molecules in understanding various therapeutic processes and manipulated significantly regulatory mechanism/s pertaining to management of diabetes through pancreatic α-amylase, intestinal α-glucosidase, insulin action, glucose uptake in different in vivo and in vitro systems. The additional inputs of nanotechnological approaches regarding further exploration of herbal chemical potential may lead to consideration of certain novel magic drug molecules and may act as an advantage in management of diabetes for betterment of mankind.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>32559845</pmid><doi>10.1016/j.biopha.2020.110198</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0753-3322 |
ispartof | Biomedicine & pharmacotherapy, 2020-07, Vol.127, p.110198-110198, Article 110198 |
issn | 0753-3322 1950-6007 |
language | eng |
recordid | cdi_proquest_miscellaneous_2415302340 |
source | Elsevier |
subjects | Diabetes Diabetes Mellitus - drug therapy Disease Management Drug Compounding - methods glucose uptake assays Humans insulin nanoparticles Nanotechnology - methods secondary metabolites α-amylase |
title | A review on ameliorative green nanotechnological approaches in diabetes management |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T23%3A59%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20review%20on%20ameliorative%20green%20nanotechnological%20approaches%20in%20diabetes%20management&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Bhardwaj,%20Monika&rft.date=2020-07&rft.volume=127&rft.spage=110198&rft.epage=110198&rft.pages=110198-110198&rft.artnum=110198&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2020.110198&rft_dat=%3Cproquest_cross%3E2415302340%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-2e317dcda0d0ec00a7539cd5eeba7983170b76742225128ca9f0ec0659cc75ab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2415302340&rft_id=info:pmid/32559845&rfr_iscdi=true |